ArticleInternational journal of molecular sciences2021

Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.

Pinar Uysal-Onganer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.